Gain Therapeutics files prospectus supplement for up to $35.5M ATM stock offering

Gain Therapeutics, Inc.

Prospectus supplement filed for ATM offering of up to $35.5M of common stock via Oppenheimer & Co.
Company previously sold $14.47M under prior ATM program dated Sept 2024, now updating under new shelf.
New S-3 registration (333-287622) became effective Nov 26, 2025; supplement dated Nov 28, 2025.
Proceeds expected for general corporate purposes; legal opinion from Lowenstein Sandler attached.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.